Search

Search Results
Results 7831 - 7840 of 8069 for Gastrointestinal
  • Meda publishes 2009 year-end report
    News - 16 Feb 2010
    “The Meda Group expects to achieve sales of about SEK 13,000 million and an EBITDA of about SEK 4,200 million for full-year 2009.”
  • Sutent
    Drug - 26 Feb 2025
    Consumer Medicine Information (CMI) about Sutent (Sunitinib malate) intended for persons living in Australia.
  • Tobramycin Viatris
    Drug - 24 Jan 2025
    Consumer Medicine Information (CMI) about Tobramycin Viatris (tobramycin) intended for persons living in Australia.
  • Tobramycin Injection
    Drug - 26 Nov 2024
    Consumer Medicine Information (CMI) about Tobramycin Injection (tobramycin sulfate) intended for persons living in Australia.
  • DBL Tobramycin Injection
    Drug - 26 Nov 2024
    Consumer Medicine Information (CMI) about DBL Tobramycin Injection (tobramycin) intended for persons living in Australia.
  • Tobramycin PF
    Drug - 26 Nov 2024
    Consumer Medicine Information (CMI) about Tobramycin PF (tobramycin) intended for persons living in Australia.
  • DBL Cisplatin Injection
    Drug - 30 Apr 2024
    Consumer Medicine Information (CMI) about DBL Cisplatin Injection (cisplatin) intended for persons living in Australia.
  • Dalacin C Capsules
    Drug - 27 Mar 2024
    Consumer Medicine Information (CMI) about Dalacin C Capsules (Clindamycin hydrochloride) intended for persons living in Australia.
  • Adcetris
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Adcetris (brentuximab vedotin) intended for persons living in Australia.
  • Clindamycin Viatris
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Clindamycin Viatris (Clindamycin phosphate) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback